Press Release: So-Young Reports Unaudited First Quarter 2026 Financial Results

Dow Jones05-22

BEIJING, May 22, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the first quarter ended March 31, 2026.

First Quarter 2026 Financial Highlights

   -- Total revenues were RMB432.8 million (US$62.7 million[1]), compared with 
      RMB297.3 million in the corresponding period of 2025. The aesthetic 
      treatment services revenues were RMB282.4 million (US$40.9 million), 
      compared with RMB98.8 million in the corresponding period of 2025, 
      exceeding the high end of guidance. 
 
   -- Net loss attributable to So-Young International Inc. was RMB49.2 million 
      (US$7.1 million), compared with net loss attributable to So-Young 
      International Inc. of RMB33.1 million in the same period of 2025. 
 
   -- Non-GAAP net loss attributable to So-Young International Inc.[2] was 
      RMB46.6 million (US$6.8 million), compared with non-GAAP net loss 
      attributable to So-Young International Inc. of RMB31.5 million in the 
      same period of 2025. 

First Quarter 2026 Operational Highlights

   -- The number of verified treatment visits to the branded aesthetic centers 
      for the quarter reached approximately 148,000, compared with 
      approximately 54,400 in the same period of 2025. The number of verified 
      aesthetic treatments performed surpassed 325,800, compared with 
      approximately 123,400 in the same period of 2025. 
 
   -- The number of active users, defined as those who visited branded 
      aesthetic centers at least once during the 12-month period ended on March 
      31, 2026, exceeded 213,000, compared with approximately 75,700 users 
      during the corresponding period in 2025. 
 
   -- The number of core members grew by over 11,700 during the quarter, 
      representing an approximately 22% sequential increase. These core members 
      contributed over 80% of aesthetic treatment services revenues, with a 
      quarterly repurchase rate nearly 80%. 
 
   -- As of March 31, 2026, So-Young had 54 fully operational branded aesthetic 
      centers (53 directly-operated, 1 franchised) across sixteen major cities: 
      Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chengdu, Wuhan, 
      Chongqing, Ningbo, Changsha, Tianjin, Xi'an, Suzhou, Hefei, Kunming and 
      Nanjing. Among them, 41 centers achieved profitability* in the first 
      quarter of 2026. In addition, 48 centers generated positive quarterly 
      operating cash flow* in the first quarter of 2026. The following table 
      shows the revenues generated by So-Young aesthetic centers, categorized 
      by their phase of development: 
 
[1] This press release contains translations of certain Renminbi (RMB) amounts 
into U.S. dollars (US$) solely for the convenience of the reader. Unless 
otherwise specified, all translations of Renminbi amounts into U.S. dollar 
amounts in this press release are made at RMB6.8980 to US$1.00, which was the 
U.S. dollars middle rate announced by the Board of Governors of the Federal 
Reserve System of the United States on March 31, 2026. 
[2] Non-GAAP net loss attributable to So-Young International Inc. is defined 
as net loss attributable to So-Young International Inc. excluding share-based 
compensation expenses, impairment of long-lived assets attributable to 
So-Young International Inc., and tax effects on non-GAAP adjustments. See 
"Reconciliation of GAAP and Non-GAAP Results" at the end of this press 
release. 
 
 
                                                    Average 
                                                    Revenue per   Average 
Phase** (Operating     Number of                    Center        Center Age 
duration)              Centers       Revenue (RMB)  (RMB)         (Month) 
---------------------  ------------  -------------  ------------  ------------ 
Ramp-up (0-3 months)             11     22,948,000     2,086,000           2.1 
---------------------  ------------  -------------  ------------  ------------ 
Growth (4-12 months)             23    109,490,000     4,760,000           8.0 
---------------------  ------------  -------------  ------------  ------------ 
Maturity (over 12 
 months)                         20    149,994,000     7,500,000          19.8 
---------------------  ------------  -------------  ------------  ------------ 
 
 
* Center-level profitability measures whether an individual aesthetic center 
achieved positive profit in a given period. It is calculated by deducting 
consumable materials costs, personnel costs, center rental expenses, center 
depreciation expenses, and other center-level operating costs from the 
company's self-operated store revenues, before allocation of any back-office 
or mid-office expenses. Quarterly operating cash flow refers to total cash 
collected from orders less center-level operating payments in a given period, 
and excluding operating expense payments made by back-office or mid-office 
departments during the same period. Center-level profitability and quarterly 
operating cash flow are metrics derived from the Company's internal management 
accounts, which have not been audited. 
** For the purposes of this table, "Phase" refers to the length of time since 
commencement of actual operations rather than the legal establishment or 
registration date of a branded aesthetic center. In cases where a center has 
been relocated, merged, or its team and customer base transferred to another 
location, the operating duration of the branded aesthetic center is calculated 
from the commencement date of the predecessor center's operations. Periods 
during which a center is temporarily closed and not conducting external 
operations (e.g., due to renovation or other suspensions of business) are 
excluded from the calculation of operating duration. Branded aesthetic centers 
that have been converted to other uses or are no longer within the reporting 
scope are excluded from the statistics. 
 

Management Commentary

Mr. Xing Jin, Co-Founder and Chief Executive Officer of So-Young, commented, "Driven by our dual-engine strategy, which emphasizes scale and efficiency, our core aesthetic center business gained further traction with record-high quarterly segment revenue and improved profitability. As the medical aesthetics industry is increasingly shaped by demand for higher quality and broader accessibility, our competitive edge across the value chain positions us well to capitalize on these trends. We will continue to enhance our standardized medical delivery capabilities and expand our network at a measured pace, while reinforcing our supply chain advantages and improving operational efficiency. We are confident that these ongoing efforts will create lasting value for our users, partners, and shareholders."

First Quarter 2026 Financial Results

Revenues

Total revenues were RMB432.8 million (US$62.7 million), an increase of 45.6% from RMB297.3 million in the same period of 2025. The increase was primarily due to business expansion of the branded aesthetic centers.

   -- Aesthetic treatment services revenues were RMB282.4 million (US$40.9 
      million), an increase of 185.8% from RMB98.8 million in the same period 
      of 2025. The increase was primarily due to the business expansion of the 
      branded aesthetic centers. 
 
   -- Information and reservation services[3] revenues were RMB80.3 million 
      (US$11.6 million), a decrease of 34.0% from RMB121.6 million in the same 
      period of 2025. The decrease was primarily due to a decrease in the 
      number of medical service providers subscribing to information services 
      on So-Young's platform. 
 
   -- Sales of medical products and maintenance services revenues were RMB57.1 
      million (US$8.3 million), an increase of 2.8% from RMB55.6 million in the 
      same period of 2025, primarily due to an increase in the order volume of 
      medical products. 
 
   -- Other services revenues were RMB12.9 million (US$1.9 million), a decrease 
      of 39.3% from RMB21.2 million in the same period of 2025, primarily due 
      to a decrease in revenues from insurance brokerage services. 
 
[3] Since the second quarter of 2025, in light of the better monitoring 
business development of branded aesthetic centers, the previous line item 
information, reservation services and others was separated into two line 
items, which are information and reservation services and other services.  The 
revenue generated from information and reservation services and other services 
for the first quarter of 2025 have also been retrospectively updated. The 
amount reclassified from previous line item information, reservation services 
and others to information and reservation services is RMB121.6 million for the 
first quarter of 2025. 
 

Cost of Revenues

Cost of revenues was RMB251.0 million (US$36.4 million), an increase of 65.8% from RMB151.4 million in the first quarter of 2025. The increase was primarily due to the business expansion of the branded aesthetic centers.

   -- Cost of aesthetic treatment services were RMB205.8 million (US$29.8 
      million), an increase of 156.4% from RMB80.3 million in the first quarter 
      of 2025. The increase was primarily due to the business expansion of the 
      branded aesthetic centers. 
 
   -- Cost of information and reservation services[4] were RMB6.4 million 
      (US$0.9 million), a decrease of 72.5% from RMB23.3 million in the first 
      quarter of 2025. The decrease was in line with the decrease in revenue 
      generated from information and reservation services. 
 
   -- Cost of medical products sold and maintenance services were RMB30.4 
      million (US$4.4 million), a decrease of 0.1% from RMB30.4 million in the 
      first quarter of 2025. The decrease was primarily due to a decrease in 
      costs associated with the sales of medical equipment. 
 

(MORE TO FOLLOW) Dow Jones Newswires

May 22, 2026 05:00 ET (09:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment